Salvage therapy for hepatocellular carcinoma with thalidomide

AIM: To evaluate the clinical benefit of thalidomide in patients with advanced hepatocellular carcinoma (hepatoma). METHODS: From March 2000 to July 2002, patients who had advanced hepatocellular carcinoma and failed to or were unsuited for aggressive treatment, were enrolled and took thalidomide 15...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :World J Gastroenterol
Главные авторы: Wang, Tsang-En, Kao, Chin-Roa, Lin, Shee-Chan, Chang, Wen-Hsiung, Chu, Cheng-Hsin, Lin, Johson, Hsieh, Ruey-Kuen
Формат: Artigo
Язык:Inglês
Опубликовано: Baishideng Publishing Group Inc 2004
Предметы:
Liver Cancer
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4716902/
https://ncbi.nlm.nih.gov/pubmed/14991931
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v10.i5.649
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы